Share on StockTwits
 

St. Jude Medical (NYSE:STJ) VP Scott Thome sold 7,500 shares of the stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $59.57, for a total transaction of $446,775.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of St. Jude Medical in a research note to investors on Thursday, January 30th. They now have a $64.00 price target on the stock. Separately, analysts at Canaccord Genuity raised their price target on shares of St. Jude Medical from $40.00 to $51.00 in a research note to investors on Thursday, January 23rd. They now have a “sell” rating on the stock. Finally, analysts at Wedbush raised their price target on shares of St. Jude Medical from $62.00 to $73.00 in a research note to investors on Tuesday, January 14th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and eleven have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $57.22.

Shares of St. Jude Medical (NYSE:STJ) traded up 2.48% on Friday, hitting $62.00. The stock had a trading volume of 5,103,145 shares. St. Jude Medical has a 1-year low of $39.79 and a 1-year high of $68.39. The stock has a 50-day moving average of $63.06 and a 200-day moving average of $56.9. The company has a market cap of $18.364 billion and a price-to-earnings ratio of 24.32.

St. Jude Medical (NYSE:STJ) last issued its quarterly earnings data on Wednesday, January 22nd. The company reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.02. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.38 billion. During the same quarter in the previous year, the company posted $0.90 earnings per share. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. Analysts expect that St. Jude Medical will post $3.98 EPS for the current fiscal year.

St. Jude Medical, Inc (NYSE:STJ) develops, manufactures and distributes cardiovascular medical devices.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.